Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cutis ; 112(5): 245-247, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38091442
2.
Clin Case Rep ; 10(3): e05210, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35280092

ABSTRACT

Bronchogenic cysts are embryologic malformations of the foregut and are rarely found head and neck region. Here we present a case of an upper scapular/lower posterior neck cystic mass which was initially suspicious for lymphatic malformation but confirmed by pathology to be an ectopic bronchogenic cyst.

4.
J Hum Genet ; 63(12): 1211-1222, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30250212

ABSTRACT

Mitochondrial dysfunction lies behind many neurodegenerative disorders, owing largely to the intense energy requirements of most neurons. Such mitochondrial dysfunction may work through a variety of mechanisms, from direct disruption of the electron transport chain to abnormal mitochondrial biogenesis. Recently, we have identified biallelic mutations in the mitochondrial flavoprotein "ferredoxin reductase" (FDXR) gene as a novel cause of mitochondriopathy, peripheral neuropathy, and optic atrophy. In this report, we expand upon those results by describing two new cases of disease-causing FDXR variants in patients with variable severity of phenotypes, including evidence of an inflammatory response in brain autopsy. To investigate the underlying pathogenesis, we examined neurodegeneration in a mouse model. We found that Fdxr mutant mouse brain tissues share pathological changes similar to those seen in patient autopsy material, including increased astrocytes. Furthermore, we show that these abnormalities are associated with increased levels of markers for both neurodegeneration and gliosis, with the latter implying inflammation as a major factor in the pathology of Fdxr mutations. These data provide further insight into the pathogenic mechanism of FDXR-mediated central neuropathy, and suggest an avenue for mechanistic studies that will ultimately inform treatment.


Subject(s)
Alleles , Iron-Sulfur Proteins/genetics , Mutation , Neurodegenerative Diseases/genetics , Oxidoreductases/genetics , Animals , Brain/enzymology , Brain/pathology , Female , Humans , Inflammation/enzymology , Inflammation/genetics , Inflammation/pathology , Iron-Sulfur Proteins/metabolism , Male , Mice , Mice, Transgenic , Neurodegenerative Diseases/enzymology , Neurodegenerative Diseases/pathology , Oxidoreductases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...